Header Logo

Connection

ANN SCHEIMANN to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications ANN SCHEIMANN has written about Cost-Benefit Analysis.
ANN SCHEIMANN
Connection Strength
0.008
Cost-Benefit Analysis
  1. Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients. Clin Transplant. 1998 Dec; 12(6):588-92.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.